Otc

Mankind's new subsidiary will have an initial paid-up capital of Rs 5 crore with a further investment of up to Rs 250 crore in one or more tranches, the press statement added.

Sebi comes out with uniform format for reporting OTC trades in non-convertible securities

The development comes after Sebi observed that information on OTC trades in listed non-convertible securities provided to the stock exchanges by the investors is incomplete and inaccurate.

Glenmark Pharmaceuticals acquires certain OTC drugs from Wockhardt in US

The acquisition by the company's fully-owned subsidiary Glenmark Pharmaceuticals Inc, USA includes the approved abbreviated new drug applications (ANDAs) for famotidine tablets, 10 mg and 20 mg used to treat and prevent ulcers in the stomach and intestine, the company said in a statement.

Piramal using e-commerce as testing ground for consumer products: CEO Nitish Bajaj

Piramal’s consumer products division is tapping celebrity endorsements, expanding distribution and leveraging e-commerce as it eyes rapid growth.

Pharma formulators to invest in growing OTC market: Report

These investments would be driven by the need to further diversify the domestic prescription business, India Ratings and Research (Ind-Ra) said in its report.

Lupin forays into OTC segment;eyes Rs 300 cr turnover in 5 years

The Mumbai-based firm has introduced its legacy product 'Softovac' across the country as an OTC medicine.

Piramal Enterprises to acquire 4 Pfizer brands for Rs 110 cr

"The company's consumer products division has entered into an agreement to acquire four brands from Pfizer Ltd for a consideration of Rs 110 crore," Piramal Enterprises said in a filing to BSE.

RBI floats discussion paper on OTC derivatives margin

"Derivatives are an integral risk management tool for business entities and financial institutions. However, derivative markets can also lead to excessive and opaque risk taking, which may result in systemic risks, especially so in the context of the over-the-counter (OTC) derivative markets," the central bank said in a notification this evening.

CCIL to be trade repository for OTC interest, forex contracts

The Reserve Bank today said Clearing Corporation Of India (CCIL) will be the designated trade repository for over-the-counter (OTC) interest rate and foreign exchange contracts.

Aurobindo gains 2%; gets final USFDA approval for OTC drug

The approved product has an estimated market size of USD 96 million for the twelve months ending January 2016 according to IMS.

Novartis India Q3 net at Rs 60 cr

Net sales during the period under review stood at Rs 183.38 crore while in the same period last fiscal it was at Rs 213.02 crore.

Aim to be among top 3 cos in OTC drugs: Piramal Enterprises

Kedar Rajadnye, COO -Consumer Products Division, indicated that the company, which has grown at 18 percent in last 4-5 years, is in line to achieve its Rs 1,000 crore revenue target by 2020.

Baby care brand will add 8-10% to topline growth: Piramal

Piramal Enterprise‘s consumer product division has acquired the baby care brand Little‘s for Rs 73 crore.

Novartis India Q2 net rises multi-fold to Rs 104 crore

The company had posted a net profit of Rs 14 crore a year ago. "The company has received a sale consideration in relation to the slump sale of the OTC division to GSK CPL amounting to Rs 1,097.3 million and the same has been accounted for in the quarter ended September 30, 2015 results," Novartis said in a note.

Money markets to remain open on all Saturdays: RBI

The forex market and government securities markets, along with all OTC derivative markets, would continue to remain closed on all Saturdays, RBI said while announcing supporting changes in its working in the wake of the government notifying public holiday on the second and fourth Saturdays of every month for all banks.

Netmeds.com and Stepathlon Introduce Medmemo, an Automated Pharmacy Record Management System

The Dadha Group owned NetMeds.com, India’s first e-marketplace for pharma to offer delivery across the country has partnered ...

FIL Capital to invest in Cipla's consumer healthcare biz

Drug major Cipla on Tuesday said its board has approved a potential investment by FIL Capital Investments (Mauritius) II Ltd in its consumer healthcare business.

Alibaba, Evergrande files for China IPO in Asian first

The company gave no size for the planned listing, which is pending approval by the NEEQ that operates China's leading over-the-counter (OTC) equity exchange.

Q2 nos drive Aurobindo Pharma to 34-month high, up 10%

The drug company's consolidated net profit rose 5.7 percent to Rs 235 crore for the second quarter ended September 30, 2013 from Rs 222.4 crore year-on-year.

Venus Remedies signs out-licensing pact; stock up 20%

Venus Remedies entered OTC (over-the-counter) category with Ezenus. Dheeraj Aggarwal, CFO, Venus Remedies says that Ezenus is our first OTC product which is a stress reliever. It works for reducing anti-toxicants in the body.

Pharma OTC: A step beyond generic drugs

As patents expire and generic drugs becoming available, pharma companies are looking forward to penetrate in the Over the Counter (OTC) market.

Sebi should allow stock lending borrowing in OTC format

The latest relaxation in the Securities Lending and Borrowing (SLB) guidelines by Sebi is unlikely to excite short sellers, feel market participants.

Goldman commodities crown slips as traders exit

At least 20 commodities traders, several senior, have left Goldman Sachs in the past months, dealing a blow to Wall Street's long-time king of commodities as talent moves to better paying trading houses and hedge funds.

Jubilant inks USD 70 m manufacturing pact with US firm

Jubilant Life Sciences today said its has signed a contract manufacturing agreement with an undisclosed US pharmaceutical firm to produce an OTC product in women health and personal care segment.

Sun Pharma gets US FDA nod; stock rise

Sun Pharmaceutical Industries has got US FDA nod to sell Cetirizine Tablets as OTC, reports CNBC-TV18, quoting NewsWire18. It touched an intraday high of Rs 530 and an intraday low of Rs 495.90. At 09:46 hrs the share was quoting at Rs 501.25, up Rs 10.95, or 2.23%.